Article
Integration of Donor Microbiota Following FMT Predicts Anti–PD-1 Response in Melanoma
2025-09-05
Abstract excerpt
<title>Abstract</title> <p>Fecal microbiota transplantation (FMT) has shown promise improving anti–PD-1 therapy in melanoma, but the underlying microbial features remain poorly defined. We performed strain-resolved metagenomic analysis of three clinical trials and found therapeutic benefit was linked to successful integration of donor microbiota, rather than increased diversity or engraftment of specific species....
Topics
Open a Topic to create a Post that cites this publication.
- Cancer Immunotherapy and Biomarkers
- Clostridium difficile and Clostridium perfringens research
- Cutaneous Melanoma Detection and Management
- Epigenetics and DNA Methylation
- Gut microbiota and health
- Helicobacter pylori-related gastroenterology studies
- Immunotherapy and Immune Responses
- Pancreatic and Hepatic Oncology Research
Identifiers and source
- Literature Corpus work
- a59559d4-97d0-5392-bc86-2e7398028079
- DOI
- 10.21203/rs.3.rs-7483676/v1
